흑염소의 프리온 단백질을 코딩하는 유전자를 포함하는 발현 벡터 및 이에 의하여 형질도입된 세포
    1.
    发明公开
    흑염소의 프리온 단백질을 코딩하는 유전자를 포함하는 발현 벡터 및 이에 의하여 형질도입된 세포 有权
    表达载体包含来自CAPRA AEGAGRUS HIRCUS和转移细胞的基因编码蛋白质

    公开(公告)号:KR1020140081447A

    公开(公告)日:2014-07-01

    申请号:KR1020120151209

    申请日:2012-12-21

    Abstract: The present invention relates to an expression vector comprising a gene encoding a prion protein of Capra hircus and a cell transduced by the vector. The present invention can be used for manufacturing a cell having polymorphism, which represents Capra hircus bred in Korea, and a transduced mouse; and can be effectively used for developing an animal experimental model for studies including diagnosis of prion diseases which include scrapie occurred in goat family animals, and for confirming if domestic TSE diseases interspecifically spread or not.

    Abstract translation: 本发明涉及一种表达载体,其包含编码Capra hircus的朊病毒蛋白的基因和由载体转导的细胞。 本发明可用于制造具有多形性的细胞,其代表在韩国繁殖的Capra hircus和转导的小鼠; 可以有效地用于研究包括诊断朊病毒疾病的动物实验模型,包括山羊家族动物发生的瘙痒病,以及确认国内TSE疾病是否特异性传播。

    복분자 추출물을 포함하는 소해면상뇌증의 예방 또는 치료용 조성물
    2.
    发明公开
    복분자 추출물을 포함하는 소해면상뇌증의 예방 또는 치료용 조성물 无效
    包含RUBI FRUCTUS提取物的组合物,用于预防或治疗BOVINE SPONIFORM ENCEPHALOPATHY

    公开(公告)号:KR1020120075678A

    公开(公告)日:2012-07-09

    申请号:KR1020100137439

    申请日:2010-12-29

    CPC classification number: A61K36/73 A23V2200/322 A61K2236/331 A61K2236/333

    Abstract: PURPOSE: A composition containing Rubi Fructus extract is provided to inhibit modified prion production and to prevent or treat BSE. CONSTITUTION: A veterinary composition for preventing or treating BSE contains Rubi Fructus extract. The extract is prepared using water, low alcohol of C1-C4, and a mixture solvent thereof. The concentration of the extract is 6.25ug/ml. The daily dose of the composition is 0.0001-100 mg/kg. A feed additive composition for preventing or treating BSE contains the extract. A feed contains the extract.

    Abstract translation: 目的:提供含有Rubi Fructus提取物的组合物,以抑制修饰的朊病毒生成并预防或治疗BSE。 组成:用于预防或治疗疯牛病的兽用组合物含有Rubi Fructus提取物。 提取物是使用水,C1-C4的低级醇及其混合溶剂制备的。 提取物的浓度为6.25ug / ml。 组合物的日剂量为0.0001-100mg / kg。 用于预防或治疗BSE的饲料添加剂组合物含有提取物。 Feed包含提取物。

    민들레 추출물을 포함하는 소해면상뇌증의 예방 또는 치료용 조성물
    7.
    发明公开
    민들레 추출물을 포함하는 소해면상뇌증의 예방 또는 치료용 조성물 有权
    组合物包含用于预防或治疗牛肝病的食物提取物

    公开(公告)号:KR1020120075677A

    公开(公告)日:2012-07-09

    申请号:KR1020100137437

    申请日:2010-12-29

    Abstract: PURPOSE: A composition containing Taraxacum officinale extract is provided to suppress BSE-modified prion production or remove the prion and to prevent or treat BSE. CONSTITUTION: A veterinary composition for preventing or treating BSE contains Taraxacum officinale extract. The composition is manufactured in the form of powder, granules, capsules, suspension, emulsion, solution, syrup, aerosol, soft or hard gelatin capsule, suppository, sterilized injection solution, and sterilized external use formulation. The extract is prepared using water, low carbon number alcohol of C1-C4, and a mixture solvent thereof. A feed additive composition for preventing or treating BSE contains the extract.

    Abstract translation: 目的:提供含有蒲公英提取物的组合物以抑制BSE修饰的朊病毒产生或去除朊病毒并预防或治疗疯牛病。 组成:用于预防或治疗疯牛病的兽用组合物含有蒲公英提取物。 组合物以粉末,颗粒,胶囊,悬浮液,乳液,溶液,糖浆,气溶胶,软或硬明胶胶囊,栓剂,灭菌注射溶液和灭菌外用制剂的形式制造。 提取物是使用C1-C4的低碳数醇及其混合溶剂制备的。 用于预防或治疗BSE的饲料添加剂组合物含有提取物。

    소해면상뇌증의 변형프리온을 감별 및 검출할 수 있는 단클론항체, 이를 생산하는 융합세포주 및 그 용도
    8.
    发明公开
    소해면상뇌증의 변형프리온을 감별 및 검출할 수 있는 단클론항체, 이를 생산하는 융합세포주 및 그 용도 有权
    用于分离和检测异常血糖的单克隆抗体引起的牛血清病毒

    公开(公告)号:KR1020110009967A

    公开(公告)日:2011-01-31

    申请号:KR1020090067436

    申请日:2009-07-23

    Abstract: PURPOSE: A monoclonal antibody for specifically detecting abnormal prion of spongiform encephalopathy is provided. CONSTITUTION: A fusion cell line of deposit number KCLRF-BP-00213 produces monoclonal antibody for detecting abnormal prion of spongiform encephalopathy. A method for preparing fusion cell line comprises: a step of inoculating a peptide of sequence number 1 to a knock-out mouse; a step of isolating B cells from the mouse; and a step of fusing the B cells and mouse myeloma-derived cells. The abnormal prion of spongiform encephalopathy is detected by western blotting using the monoclonal antibody.

    Abstract translation: 目的:提供特异性检测海绵状脑病异常朊病毒的单克隆抗体。 构成:存在编号为KCLRF-BP-00213的融合细胞系产生用于检测海绵状脑病异常朊病毒的单克隆抗体。 制备融合细胞系的方法包括:将序列号1的肽接种到敲除小鼠的步骤; 从小鼠中分离出B细胞的步骤; 以及融合B细胞和小鼠骨髓源性细胞的步骤。 使用单克隆抗体通过western印迹检测海绵状脑病的异常朊病毒。

Patent Agency Ranking